You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Stiefel Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for STIEFEL, and what generic and branded alternatives to STIEFEL drugs are available?

STIEFEL has five approved drugs.

Summary for Stiefel

US Patents:	0
Tradenames:	4
Ingredients:	4
NDAs:	5
Patent Litigation for Stiefel:	See patent lawsuits for Stiefel

Drugs and US Patents for Stiefel

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Stiefel Labs Inc	SORIATANE	acitretin	CAPSULE;ORAL	019821-002	Oct 28, 1996		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Stiefel	DUAC	benzoyl peroxide; clindamycin phosphate	GEL;TOPICAL	050741-001	Aug 26, 2002	AB	RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Stiefel Labs Inc	SORIATANE	acitretin	CAPSULE;ORAL	019821-003	Aug 6, 2009		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Stiefel Labs Inc	SORIATANE	acitretin	CAPSULE;ORAL	019821-004	Aug 6, 2009		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Stiefel	SCABENE	lindane	LOTION;TOPICAL	086769-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Stiefel

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Stiefel	DUAC	benzoyl peroxide; clindamycin phosphate	GEL;TOPICAL	050741-001	Aug 26, 2002	5,466,446	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for STIEFEL drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Gel	1% / 5%	➤ Subscribe	2008-12-11

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.